IPCALAB — Ipca Laboratories Balance Sheet
0.000.00%
Last trade - 00:00
- IN₹339.44bn
- IN₹363.06bn
- IN₹62.44bn
2019 March 31st | 2020 March 31st | C2021 March 31st | R2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 3,716 | 4,182 | 7,688 | 13,701 | 21,874 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 8,902 | 10,783 | 10,325 | 11,547 | 11,899 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 23,778 | 28,557 | 34,370 | 44,572 | 51,893 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 17,826 | 19,933 | 21,465 | 25,026 | 26,946 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 45,507 | 52,598 | 60,684 | 76,235 | 86,264 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 10,975 | 13,264 | 11,605 | 14,659 | 18,058 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 14,283 | 16,324 | 13,667 | 21,587 | 27,844 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 31,224 | 36,275 | 47,017 | 54,648 | 58,420 |
Total Liabilities & Shareholders' Equity | 45,507 | 52,598 | 60,684 | 76,235 | 86,264 |
Total Common Shares Outstanding |